-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Conclusions: These recommendations can guide clinical practice and future research to improve CVR management
Source: Drosos GC, Vedder D, Houben E , et al .
Drosos GC, Vedder D, Houben E , et al .
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Annals of the Rheumatic DiseasesPublished Online First: 02 February 2022.
doi: 10.
1136/annrheumdis -2021-221733 , et al Annals of the Rheumatic Diseases
leave a message here